Information  X 
Enter a valid email address

Lipoxen PLC (XEN)

  Print      Mail a friend

Thursday 25 September, 2008

Lipoxen PLC

Director/PDMR Shareholding

RNS Number : 2583E
Lipoxen PLC
25 September 2008
 



Lipoxen plc 

('Lipoxen' or the 'Company')


Director dealings


The Company was informed on 24 September that on 23 September FDS Pharma ('FDS') disposed of 100,00 ordinary shares of 0.5p each ('Ordinary Shares') at 18 pence each


FDS directors and partners Dr Dimitry D. Genkin and Dr Tatiana Zhuravskaya are non-executive directors of Lipoxen. Following this disposal they, through FDS, have an interest in Lipoxen of 43,255,316 Ordinary Shares, representing 36.2 per cent of the issued Ordinary Share capital in the Company.


Enquires:


Lipoxen plc

+44 (0)20 7691 3583


Scott Maguire, Chief Executive Director



Colin Hill, Finance Director





Landsbanki Securities (UK) Limited 

(nominated adviser)

+44 (0)20 7426 9000


Shaun Dobson / Claes Spång





Citigate Dewe Rogerson

+44 (0)20 7638 9571


David Dible / Heather Keohane




This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSMGGZLNDRGRZM